Abstract

BackgroundTo investigate a prognostic role of gross tumor volume (GTV) changes on survival outcomes following concurrent chemoradiotherapy (CCRT) in stage III non-small-cell lung cancer (NSCLC) patients.MethodsWe enrolled 191 patients with stage III NSCLC from 2001 to 2009 undergoing definitive CCRT. The GTV of 157 patients was delineated at the planning CT prior to CCRT and with a follow-up CT 1 month after CCRT. We assessed the volumetric parameters of pre-treatment GTV (GTVpre) post-treatment GTV (GTVpost), and volume reduction ratio of GTV (VRR). The primary endpoint was overall survival (OS) and secondary endpoints were progression-free survival (PFS) and locoregional progression-free survival (LRPFS). The best cut-off value was defined as that which exhibited the maximum difference between the two groups.ResultsThe median follow-up duration was 52.7 months in surviving patients. Median survival, 3-year OS, PFS and LRPFS rates were 25.5 months, 36.4%, 23.0%, and 45.0%, respectively. The selected cut-off values were 50 cm3 for GTVpre, 20 cm3 for GTVpost, and 50% for VRR. The smaller GTVpre and GTVpost values were associated with better OS (p < 0.001 and p = 0.015) and PFS (p = 0.001 and p = 0.004), respectively, upon univariate analysis. The higher VRR of > 50% was associated with a trend toward poorer OS (p = 0.004) and PFS (p = 0.054). Upon multivariate analysis, smaller GTVpre indicated significantly improved OS (p = 0.001), PFS (p = 0.013) and LRPFS (p = 0.002), while smaller GTVpost was marginally significant for PFS (p = 0.086). Higher VRR was associated with a trend toward poorer OS (p = 0.075).ConclusionsIn patients with stage III NSCLC undergoing definitive CCRT, GTVpre was an independent prognostic factor of survival. Notably, improved outcome was not correlated with higher VRR after short-term follow-up with CT alone.Electronic supplementary materialThe online version of this article (doi:10.1186/s13014-014-0283-6) contains supplementary material, which is available to authorized users.

Highlights

  • To investigate a prognostic role of gross tumor volume (GTV) changes on survival outcomes following concurrent chemoradiotherapy (CCRT) in stage III non-small-cell lung cancer (NSCLC) patients

  • We performed volumetric survival analysis to investigate the prognostic role of gross tumor volume (GTV) before and after treatment on survival outcomes in stage III NSCLC patients treated with CCRT

  • We confirmed that smaller GTVpre was associated with better survival

Read more

Summary

Introduction

To investigate a prognostic role of gross tumor volume (GTV) changes on survival outcomes following concurrent chemoradiotherapy (CCRT) in stage III non-small-cell lung cancer (NSCLC) patients. Definitive radiotherapy with concurrent chemotherapy (CCRT) has been the mainstay of treatment for unresectable or medically inoperable stage III non-small cell lung cancer (NSCLC), and offers a greater chance of survival compared with sequential chemoradiotherapy [1,2]. In patients with stage III NSCLC treated with CCRT, the response rate may reflect sensitivity to both RT and chemotherapy or tumor kinetics. It is not known whether the response rate or tumor volume changes after CCRT are associated with prognosis. We performed volumetric survival analysis to investigate the prognostic role of gross tumor volume (GTV) before and after treatment on survival outcomes in stage III NSCLC patients treated with CCRT

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call